267 related articles for article (PubMed ID: 1154455)
1. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
de la Pena A; Chenault CB; Goldzieher JW
Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
Leis D; Botterman P; Ermler R; Maurer U
Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
[TBL] [Abstract][Full Text] [Related]
7. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
8. Ethinyl estradiol in peripheral plasma after oral administration of 30 microgram and 50 microgram to women.
Nilsson S; Nygren KG
Contraception; 1978 Nov; 18(5):469-75. PubMed ID: 729373
[TBL] [Abstract][Full Text] [Related]
9. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
10. Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.
Goldzieher JW
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):318-22. PubMed ID: 2196804
[TBL] [Abstract][Full Text] [Related]
11. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
[TBL] [Abstract][Full Text] [Related]
12. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
Sato N; Yanaihara T; Kanazawa M; Okinaga S; Arai K
Nihon Naibunpi Gakkai Zasshi; 1976 Aug; 52(8):845-50. PubMed ID: 797581
[TBL] [Abstract][Full Text] [Related]
13. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
Miller JF; Fotherby K; Bye PG; Elstein M
Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
[TBL] [Abstract][Full Text] [Related]
14. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
16. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
Rangnekar KN; Rao SS; Joshi UM
Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
[TBL] [Abstract][Full Text] [Related]
17. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
Coutinho EM; Silva AR; Carreira C; Barbosa I
Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
[TBL] [Abstract][Full Text] [Related]
18. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
19. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
